Foot problems are a major cause of morbidity, mortality and disability in diabetic patients. Diabetes mellitus is a relatively common disorder that affects over 16 million people in the United States. 1 The World Health Organization predicts that the world population of diabetics will double to over 200 million people by the year 2010. 2 Diabetes affects patients of all ages and in all socioeconomic segments of the population. There are over 625 000 newly diagnosed diabetics in the US each year. 3 There is a high cost associated with diabetes. The health care costs due to morbidity and complications of diabetes mellitus are higher for diabetics than the general population. In addition, there are indirect costs to society from diabetic complications resulting in loss of productivity. Diabetics utilize health care resources at a rate three times higher than the average American. When evaluated in terms of outpatient contacts with health care providers, diabetics have 15.5 encounters per person compared to 5.5 contacts per year for the general population. 4 Diabetes is the most common reason for nontraumatic lower extremity amputations in the US. There were 50 000 lower extremity amputations in diabetics in one year. Foot ulcers preceded amputations 85% of the time in diabetics. 5 This places an enormous burden on the resources for health care. In addition, there is up to 68% mortality in diabetics within 5 years of lower extremity amputation. 6
Onychomycosis in the diabetic patient
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Prevalence of onychomycosis in the diabetic population
Onychomycosis is the most common nail disorder and probably represents about 30% of cutaneous fungal infec-tions. In a study of 550 patients with diabetes, Gupta and Konnikov 7 evaluated the prevalence of onychomycosis in the diabetic population. They found clinically abnormal nails with mycologic evidence of fungal disease in approximately one third of diabetics. The presence of onychomycosis was correlated with age and with male gender. In fact, men with diabetes were 2.99 times as likely to have onychomycosis as diabetic women. The overall risk ratio of diabetics having onychomycosis is 2.77 compared to age and sex matched nondiabetic controls. 7 How does onychomycosis pose a problem for the diabetic patient?
Diabetes mellitus causes complications in a number of organ systems including renal, ocular, cardiovascular, neurologic, and cutaneous. The cutaneous findings of the lower extremity are generally related to peripheral vascular disease and diabetic neuropathy. Not all diabetics are at risk of lower extremity complications from their onychomycosis; high-risk diabetic patients have sensory neuropathy, compromised peripheral vascular system, and immunopathy. The diabetic foot is a complex concept that has many features including neuropathy, impaired wound healing, immune compromise, peripheral vascular disease, and trauma and infection.
While mild early onychomycosis probably poses little threat to the diabetic, more severe, neglected onychomycosis can be a more serious problem. In particular, the high-risk diabetic with compromised lower extremities and severe neuropathy is at increased risk of developing complications from onychomycosis. Onychomycosis results in thick, yellow brittle nails that can be sharp, pointed and result in injury to the surrounding skin. The diabetic with neuropathy does not notice small cuts and breaks in the skin which can become a portal of entry for bacteria. These minor infections, when ignored, can escalate into serious paronychia and cellulitis (Fig. 1) . Just as tight shoes can cause a friction blister in the neuropathic diabetic, thickened, dystrophic mycotic nails can cause pressure erosions of the nail bed and hyponychium. These breaks in the skin may remain unnoticed due to sensory neuropathy and result in serious limb-threatening bacterial infections (Figs 2-3) . Osteomyelitis can result from neglected, infected nail bed erosion in the diabetic because of the close proximity of the nail bed to the underlying bone. It is not known how many diabetics have potentially preventable bad outcomes as a result of their untreated onychomycosis. Amputations of the lower extremities are a common cause of morbidity in diabetics and a significant expense to Cellulitis and deep space infection in a type 1 diabetic young man with chronic tinea pedis and web space fissuring society. Acute and chronic tinea pedis when neglected can become a problem for the diabetic. Interdigital web-space tinea pedis can lead to cracks and fissures that become secondarily infected, resulting in serious deep space infection (Fig. 4) .
Management of onychomycosis in the diabetic patient
Treatment of toenail onychomycosis in the high-risk diabetic patient requires a three pronged approach: oral antifungal therapy, mechanical measures, and patient education. 
Antifungal therapy
The cornerstone of the management of fungal skin and nail diseases in the diabetic patient is oral antifungal therapy. It is the author's opinion that the diabetic patient's nails should be cleared and maintained free of fungus indefinitely. Issues to consider when treating diabetics with oral antifungal medication are the following: efficacy, compliance, concomitant medications, and cost. Relapse/ reinfection is seen in this population and is possibly due to impaired lower extremity circulation, slow growth of nails and immunopathy. There is a role for the concomitant use of topical antifungal drugs for relapse/reinfection prevention.
Mechanical intervention
Physical debridement of the fungal nail by manual, or electric means by a health care professional is an important part of the management of diabetic feet and toenails. Avulsion is rarely indicated, but there is a place for grinding and debridement of sharp, thick nails that are otherwise difficult to manage and risky to ignore (Fig. 4) . If an electric file or grinder is used to reduce thickened fungal nails, a mask should be worn to avoid inhaling the nail dust and fungal particles.
Patient education
The high-risk diabetic patient should be educated about the importance of proper foot care, and should be instructed to examine his or her feet daily. Self-examination should include careful inspection of the web spaces, heels, and parionychium with particular attention to small cuts and breaks in the skin. These small cuts may seem insignificant, but when left untreated can lead to serious problems. The patient should be reminded that he can not rely on pain and discomfort to signal skin integrity breaks because sensation is often abnormal due to diabetic neuropathy. It is beneficial to use each office contact with a diabetic patient as an opportunity to examine the feet and nails and talk to the patient about the importance of general foot care and prevention of fungal disease. By examining the feet and nails of every diabetic seen in the office no matter what his chief complaint, the physician emphasizes the importance of the health and welfare of his feet and toenails.
Conclusions
For every diabetic patient who is spared the consequences of amputation, the cost reduction in terms of health care dollars as well as of morbidity, mortality, and disability is significant. The expense and effort needed to treat onychomycosis in all diabetics is well spent. Lower extremity amputation in diabetics is the primary cause of disability and death in this population. Education of the diabetic patient about the importance of foot and nail care is paramount.
